No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Zinbryta is a central nervous system (CNS) drug used to treat multiple sclerosis (MS). It is a monoclonal antibody that works by targeting a specific protein in the body that is involved in the inflammation associated with MS. It is administered by injection and is typically used in combination with other MS treatments. Zinbryta is approved for use in the United States, Europe, and other countries.
The CNS drug market is a rapidly growing sector of the pharmaceutical industry. It is estimated that the global CNS drug market will reach $100 billion by 2025. CNS drugs are used to treat a variety of neurological disorders, including MS, Alzheimer's disease, Parkinson's disease, and epilepsy.
The Zinbryta market is a subset of the CNS drug market. It is a relatively small market, but it is growing rapidly due to the increasing prevalence of MS.
Some companies in the Zinbryta market include Biogen, AbbVie, and Merck. Show Less Read more
